Datasets:
tahasawan
/
Health_Dataset

Dataset card Data Studio Files
xet
 Community
2
Country
stringclasses
20 values
Year
int64
2k
2.02k
Disease Name
stringclasses
20 values
Disease Category
stringclasses
11 values
Prevalence Rate (%)
float64
0.1
20
Incidence Rate (%)
float64
0.1
15
Mortality Rate (%)
float64
0.1
10
Age Group
stringclasses
4 values
Gender
stringclasses
3 values
Population Affected
int64
1k
1,000k
Healthcare Access (%)
float64
50
100
Doctors per 1000
float64
0.5
5
Hospital Beds per 1000
float64
0.5
10
Treatment Type
stringclasses
4 values
Average Treatment Cost (USD)
int64
100
50k
Availability of Vaccines/Treatment
stringclasses
2 values
Recovery Rate (%)
float64
50
99
DALYs
int64
1
5k
Improvement in 5 Years (%)
float64
0
10
Per Capita Income (USD)
int64
502
100k
Education Index
float64
0.4
0.9
Urbanization Rate (%)
float64
20
90
Nigeria
2,014
Zika
Respiratory
19.55
11.39
9.65
19-35
Male
808,334
95.38
3.05
9.96
Therapy
10,561
No
76.6
1,517
3.75
6,733
0.69
41.75
Italy
2,019
Parkinson's Disease
Neurological
7.86
11.62
4.49
61+
Male
461,301
57.71
4.58
4.43
Medication
7,373
No
72.27
4,989
1.04
71,945
0.81
43.67
Mexico
2,006
Ebola
Neurological
13.79
11.33
3.77
0-18
Female
271,269
51.77
4.66
0.52
Surgery
38,674
Yes
92.08
758
4.99
30,397
0.7
36.38
Saudi Arabia
2,023
Cholera
Viral
5.85
3.44
1.98
61+
Female
495,571
76.08
1.54
4.51
Medication
21,081
Yes
54.43
1,666
9.81
23,578
0.45
53.75
Japan
2,019
Dengue
Autoimmune
19.73
9.45
3.46
0-18
Male
485,580
70.88
1.88
4.25
Medication
46,130
No
95.33
2,429
3.24
43,160
0.55
69.6
Nigeria
2,022
Rabies
Bacterial
7.52
5.48
0.79
19-35
Female
356,524
95.79
2.82
1.89
Therapy
28,844
No
75.59
3,733
0.41
3,366
0.61
55.05
Mexico
2,012
Measles
Viral
1.38
2.68
4.4
19-35
Male
536,766
54.72
3.67
5.62
Surgery
39,501
No
84.53
3,375
6.88
61,532
0.75
42.61
Japan
2,021
Rabies
Metabolic
5.07
1.84
5.82
19-35
Female
799,746
82.7
3.05
4.79
Vaccination
38,929
No
59.74
2,835
0.05
42,870
0.62
34.63
China
2,001
Zika
Chronic
17.58
13.55
1.24
36-60
Other
19,064
61.06
3.53
3.46
Medication
3,599
Yes
64.94
3,493
7.98
55,656
0.46
38.88
Australia
2,023
Leprosy
Viral
15.88
7.06
4.39
19-35
Female
798,913
83.71
4.77
1.14
Therapy
11,473
No
78.43
50
9.66
86,234
0.51
62.34
USA
2,001
Alzheimer's Disease
Chronic
15.92
0.31
0.2
36-60
Male
653,764
95.67
3.57
2.95
Vaccination
48,126
No
72.62
2,622
6.4
11,783
0.85
53.47
France
2,020
Tuberculosis
Neurological
9.13
13.68
4.57
61+
Other
88,365
58.66
1.74
7.52
Therapy
44,342
No
54.69
3,799
8.57
7,982
0.41
87.38
USA
2,005
COVID-19
Genetic
7.45
13.13
6.72
19-35
Other
985,973
59.19
4.62
1.41
Medication
35,309
No
64.1
3,353
2.17
9,984
0.9
43.01
Japan
2,016
Influenza
Chronic
1.82
11.86
2.39
0-18
Other
450,550
65.27
4.12
3.23
Therapy
8,204
No
82.65
3,240
6.3
27,471
0.7
72.89
Australia
2,013
COVID-19
Bacterial
11.45
11.28
9.36
61+
Female
324,553
52.03
4.66
5.91
Medication
13,303
Yes
51.05
1,780
9.1
14,702
0.89
32.78
South Korea
2,006
Cancer
Metabolic
4.78
6.86
0.12
36-60
Male
898,336
76.11
1.99
7.09
Therapy
9,581
Yes
74.45
3,972
4.11
66,146
0.59
50.57
South Africa
2,011
HIV/AIDS
Autoimmune
8.82
0.94
3.38
0-18
Male
608,766
72.23
2.7
1.54
Surgery
26,357
Yes
55.16
2,088
4.96
24,979
0.87
55.16
Mexico
2,004
Measles
Genetic
6.23
2.53
3.12
36-60
Male
331,715
61.06
2.65
5.82
Therapy
25,583
Yes
74.28
1,797
7.39
51,635
0.59
59.05
France
2,002
Influenza
Viral
8.39
10.3
7
36-60
Female
566,300
55.09
2.72
1.36
Therapy
28,493
No
95.1
3,303
3.34
6,911
0.69
21.25
South Africa
2,022
Polio
Cardiovascular
18.88
11.8
9.99
36-60
Female
561,212
75.27
3.67
4.79
Medication
15,088
No
67.72
2,669
2.56
84,467
0.76
61.49
Canada
2,002
Cholera
Neurological
19.53
1.97
2.08
36-60
Male
328,948
50.86
1.99
8.73
Surgery
2,507
Yes
62.29
4,595
1.04
71,946
0.45
51.67
Indonesia
2,009
Cholera
Neurological
15.11
6.88
2.52
19-35
Female
809,983
58.8
3.66
7.47
Vaccination
34,655
Yes
74.81
989
0.24
48,252
0.6
74.73
Brazil
2,013
Leprosy
Respiratory
14.42
12.89
1.1
61+
Female
630,793
61.59
0.51
2.2
Vaccination
44,286
Yes
95.19
3,132
8.33
82,161
0.72
67.63
UK
2,003
Malaria
Metabolic
9.46
1.89
8.11
19-35
Male
505,295
65.92
2.7
6.67
Surgery
25,105
Yes
62.69
672
6.83
27,442
0.83
21.12
Indonesia
2,013
Hepatitis
Bacterial
12.12
10.46
9.68
19-35
Male
849,820
77.26
4.23
0.65
Surgery
38,737
Yes
71.31
4,545
8.27
13,662
0.43
72.88
Japan
2,003
Leprosy
Metabolic
18.35
4.56
7.08
36-60
Female
90,090
57.82
2.52
7.92
Medication
49,392
No
94.6
3,826
4.51
82,818
0.81
34.35
Mexico
2,006
Influenza
Respiratory
8.87
9.33
2.73
36-60
Other
232,757
83.33
4.64
4.05
Vaccination
45,105
No
64.62
3,520
1.46
65,177
0.61
22.67
Italy
2,006
Polio
Metabolic
9.4
11.78
6.43
19-35
Female
39,955
98.33
0.7
6.89
Medication
17,911
Yes
68.46
2,148
7.8
46,301
0.55
61.11
Russia
2,008
Asthma
Genetic
9.2
5.62
8.11
36-60
Female
190,835
53.99
3.77
4.45
Vaccination
12,362
No
53.92
4,800
9.13
73,195
0.58
84.25
Russia
2,005
Dengue
Viral
5.73
2.78
6.74
61+
Male
462,925
93.04
4.39
7.76
Medication
34,429
No
84.51
304
9.64
52,338
0.62
41.79
China
2,009
Hypertension
Metabolic
15.4
8.81
9.02
36-60
Male
795,379
63.58
1.45
3.58
Vaccination
44,457
No
75.81
3,048
5.18
5,409
0.54
65.67
Japan
2,002
Leprosy
Cardiovascular
15.39
12.12
4.78
0-18
Male
264,016
86.42
3.74
4.81
Medication
14,256
No
63.08
1,059
1.18
63,922
0.49
54.95
Russia
2,008
Rabies
Viral
1.42
6.87
2.96
0-18
Female
556,432
79.68
2.06
3.67
Vaccination
47,012
No
77.54
2,281
0.08
8,752
0.86
77.92
Argentina
2,006
Leprosy
Infectious
16.05
14
9.57
19-35
Male
786,438
83.81
0.51
4.13
Vaccination
632
No
87.45
1,712
1.49
40,332
0.55
31.49
Mexico
2,021
Cholera
Neurological
17
0.51
4.65
61+
Other
576,477
82.73
4.46
4.31
Surgery
33,907
Yes
81.74
219
7.84
56,471
0.72
24.53
France
2,003
Ebola
Neurological
15.22
10.33
1.46
61+
Other
572,869
86.4
4.68
6.92
Therapy
37,460
No
97.31
186
5.59
71,778
0.86
28
Germany
2,022
Leprosy
Bacterial
12.75
5.26
0.12
19-35
Male
932,796
56.17
3.74
3.74
Therapy
14,925
No
59.29
4,043
2.43
49,037
0.85
30.38
Turkey
2,020
COVID-19
Cardiovascular
14.63
4.26
2.67
36-60
Other
189,141
92.46
0.7
8.98
Therapy
27,140
Yes
61.52
2,571
7.65
80,634
0.73
78.65
Saudi Arabia
2,010
Hypertension
Chronic
9.76
12.87
1.03
0-18
Female
180,999
55.04
2.59
3.91
Therapy
45,581
Yes
77.07
3,574
0.44
30,186
0.86
48.1
Argentina
2,000
Hypertension
Infectious
13.67
12.83
6.94
61+
Male
363,360
53.59
1.82
6.26
Surgery
12,141
No
53.56
3,558
8.86
22,310
0.41
20.53
Indonesia
2,017
Parkinson's Disease
Bacterial
10.98
9.7
5.39
0-18
Other
361,064
55.71
2.84
0.64
Vaccination
41,744
Yes
51.69
4,440
7.76
7,192
0.76
60.87
France
2,000
Alzheimer's Disease
Autoimmune
12.52
6.73
4.61
19-35
Female
209,982
59.8
1.88
6.53
Vaccination
32,484
No
73.7
3,778
1.07
866
0.61
63.41
South Korea
2,013
Cholera
Bacterial
17.24
13
6.09
0-18
Female
475,133
89.55
3.45
3.02
Medication
24,813
Yes
56.29
3,904
9.77
60,358
0.83
60.29
Brazil
2,008
Alzheimer's Disease
Autoimmune
6.46
13.76
2.27
36-60
Male
998,568
92.71
4.47
6.06
Vaccination
38,135
No
67.41
4,249
0.47
16,932
0.46
58.73
Nigeria
2,000
Dengue
Metabolic
15.65
10.07
1.4
61+
Female
290,272
76.9
1.83
7.91
Vaccination
1,774
No
76.34
2,551
7.5
87,464
0.75
37.15
USA
2,023
HIV/AIDS
Parasitic
6.87
12.19
8.07
0-18
Male
154,673
99.94
1.16
3.04
Therapy
36,734
Yes
55.05
2,507
7.33
89,593
0.42
21.39
Turkey
2,003
Leprosy
Genetic
5.23
0.9
9.16
19-35
Female
481,752
58.82
0.64
9.54
Therapy
38,810
Yes
98.89
1,344
3.57
99,265
0.72
53.62
Italy
2,007
Measles
Respiratory
11.38
5.57
0.99
36-60
Male
295,698
53.59
3.58
8.23
Medication
24,950
Yes
91.66
4,069
6.1
63,691
0.56
64.77
Turkey
2,006
Polio
Parasitic
18.46
7.78
6.42
61+
Other
232,518
72
3.82
8.28
Therapy
10,978
No
58.57
2,663
8.84
91,495
0.87
46.95
Turkey
2,000
HIV/AIDS
Autoimmune
15.25
2.38
8.78
0-18
Male
700,885
65.14
4.38
9.87
Medication
46,322
Yes
74.12
4,389
6.7
50,561
0.53
67.75
South Africa
2,004
Ebola
Respiratory
12.68
7.07
0.53
61+
Male
589,027
61.23
1.94
1.42
Vaccination
39,038
Yes
77.24
1,346
4.65
63,415
0.73
20.52
UK
2,015
Rabies
Bacterial
9.72
4.59
1.59
61+
Female
192,154
82.83
2.65
8.61
Surgery
37,104
Yes
89.68
1,597
4.22
27,441
0.87
34.22
Russia
2,017
Measles
Bacterial
12.64
0.51
6.44
0-18
Female
394,381
98.55
1.48
9.32
Surgery
44,191
Yes
67.3
1,832
1.85
34,263
0.49
58.29
Canada
2,019
HIV/AIDS
Viral
13.73
0.58
8.07
36-60
Female
637,923
87.26
4.84
1.27
Surgery
29,201
No
92.88
4,398
8.46
19,062
0.53
52.06
Argentina
2,022
Rabies
Neurological
13.15
2.66
7.18
19-35
Other
691,168
76.71
2.17
5.58
Surgery
48,484
Yes
51.77
2,223
1.78
21,498
0.52
26.58
Italy
2,016
Leprosy
Neurological
0.72
11.12
0.43
19-35
Female
628,421
53.98
3.85
6.64
Vaccination
32,105
Yes
96.37
107
7.41
92,251
0.41
75.33
Canada
2,005
Hepatitis
Genetic
16.07
4.32
0.85
61+
Male
406,260
93.68
3.19
9
Therapy
23,364
Yes
72.06
1,313
2.7
35,441
0.46
60.44
Australia
2,003
Rabies
Infectious
14.7
13.3
4.37
36-60
Female
689,317
53.79
1.15
3.96
Surgery
37,545
Yes
80.06
2,920
5.44
95,185
0.68
87.79
Australia
2,004
Malaria
Respiratory
7.33
9.26
9.53
61+
Other
217,316
58.48
2.27
1.99
Surgery
47,182
Yes
79.09
4,515
3.79
10,282
0.44
82.55
Turkey
2,009
Malaria
Autoimmune
13.13
6.01
2.89
61+
Male
304,189
63.79
3.76
2.54
Therapy
19,007
Yes
97.78
1,560
8.89
73,363
0.45
26.6
Australia
2,019
Hepatitis
Cardiovascular
5.08
11.98
4.77
36-60
Other
945,415
80.87
4.89
7.25
Surgery
34,824
Yes
74.91
3,394
5.48
86,523
0.69
51.63
Mexico
2,023
Rabies
Chronic
14.09
7.69
5.95
19-35
Female
242,948
72.29
1.9
2.52
Vaccination
1,511
Yes
86.31
2,203
6.46
99,126
0.73
83.38
Indonesia
2,023
Zika
Parasitic
10.39
8.03
2.37
19-35
Male
619,109
51.8
1.63
6.18
Surgery
7,457
Yes
59.54
4,077
8.75
56,532
0.78
71.47
Germany
2,000
Ebola
Respiratory
8.45
2.42
2.2
19-35
Male
750,763
54.93
2.94
4.5
Therapy
44,109
Yes
67.48
3,706
1.44
85,564
0.79
39.27
Turkey
2,008
Polio
Neurological
2.04
2.33
2.06
36-60
Female
169,432
78.75
2.59
2.38
Surgery
15,875
No
54.88
2,154
7.17
13,979
0.77
34.48
Australia
2,011
Cancer
Respiratory
19.43
13.49
5.76
19-35
Other
315,669
64.04
3.1
6.1
Therapy
36,173
No
85.17
2,058
6.77
46,509
0.85
86.16
UK
2,007
Hypertension
Genetic
3.42
4.23
8.49
0-18
Male
183,719
70.07
2.18
8.3
Therapy
32,051
Yes
66.06
4,060
4.37
27,358
0.86
54.33
Japan
2,003
Influenza
Parasitic
2.36
6.66
4.84
36-60
Other
332,304
74.38
4.48
7.6
Surgery
9,824
No
82.29
4,840
1.11
77,515
0.42
52.51
South Korea
2,016
Hypertension
Genetic
7.71
6.35
8.17
0-18
Female
468,599
52.19
2.45
1.54
Medication
20,535
No
58.73
4,085
2.92
68,288
0.73
61.3
Canada
2,010
Asthma
Genetic
6.29
2.81
7.6
0-18
Other
62,204
99.96
1.46
4.67
Medication
4,038
Yes
52.41
4,064
5.52
8,592
0.46
58.71
Nigeria
2,000
Zika
Respiratory
9.5
14.66
4.95
36-60
Male
375,401
82.3
3.75
6.98
Surgery
47,533
No
95.28
636
8.24
58,795
0.6
78.13
Nigeria
2,007
Malaria
Respiratory
5.4
10.35
8.46
61+
Other
148,837
70.61
4.85
4.59
Medication
42,325
Yes
78.16
1,721
7.62
32,308
0.54
34.73
India
2,009
Asthma
Respiratory
11.09
0.61
0.19
61+
Male
443,507
98.45
1.62
1.21
Medication
35,639
Yes
74.77
3,610
9.78
16,646
0.8
28.3
China
2,007
Leprosy
Autoimmune
18.57
0.33
1.47
36-60
Male
367,840
65.1
0.62
2.21
Therapy
37,204
Yes
66.61
1,540
5.32
82,814
0.65
70.26
Indonesia
2,011
Alzheimer's Disease
Genetic
13.23
8.9
6.4
19-35
Female
125,602
98.84
4.31
4.69
Surgery
25,257
No
70.73
2,148
8.5
48,290
0.58
79.54
South Africa
2,001
Alzheimer's Disease
Metabolic
7.92
4.81
1.69
19-35
Other
265,689
61.93
3
3.77
Therapy
24,301
No
62.54
2,801
3.25
31,323
0.56
36.91
USA
2,021
Rabies
Genetic
15.35
10.93
0.54
36-60
Female
8,728
66.2
1.69
1.05
Medication
42,635
Yes
86.55
3,624
3.53
7,943
0.8
56.1
Brazil
2,022
HIV/AIDS
Chronic
11.8
1.9
1.45
36-60
Other
959,393
55.91
4.21
9.55
Vaccination
39,717
Yes
50.28
4,973
3.61
50,253
0.72
57.75
China
2,022
Asthma
Parasitic
4.74
6.86
1.66
0-18
Male
428,767
86.24
3.82
3.85
Medication
7,898
Yes
77.22
3,685
9
14,674
0.52
75.99
Brazil
2,001
Cancer
Parasitic
0.15
12.68
9.36
19-35
Male
358,457
97.03
3.15
6.79
Therapy
28,228
No
59.11
3,346
0.07
41,284
0.52
55.24
India
2,015
Alzheimer's Disease
Autoimmune
12.35
14.64
6.32
36-60
Other
32,305
76.42
1.74
5.01
Medication
42,769
Yes
64.54
3,568
2.77
17,326
0.74
52.36
Saudi Arabia
2,001
Influenza
Respiratory
6.68
3.93
9.73
36-60
Other
802,738
71.68
4.35
1.38
Vaccination
44,612
Yes
96.69
2,209
0.89
9,898
0.49
78.04
South Africa
2,005
Rabies
Neurological
8.11
13.14
9.33
36-60
Female
525,325
63.96
0.61
1.57
Surgery
32,127
Yes
51.47
2,488
0.65
98,783
0.6
68.8
USA
2,013
Ebola
Neurological
13.76
13.48
9.18
61+
Female
919,588
56.96
3.27
5.96
Vaccination
30,471
No
78.52
4,318
9.34
60,015
0.77
53.76
Turkey
2,006
Ebola
Cardiovascular
9.16
3.2
8.38
36-60
Female
191,854
73.53
4.83
8.98
Vaccination
29,739
No
92.12
127
8.42
76,532
0.59
80.95
Indonesia
2,001
COVID-19
Bacterial
6.8
4.31
2.88
36-60
Other
581,445
92.98
4.55
3.23
Medication
23,536
Yes
81.97
261
2.62
3,910
0.69
38.9
Russia
2,021
Diabetes
Chronic
15.84
11.62
2.26
61+
Female
717,792
82.71
3.15
0.52
Medication
13,191
Yes
68.02
3,343
3.23
94,326
0.79
32.73
Turkey
2,007
Malaria
Respiratory
9.25
4.64
8.21
61+
Male
681,172
70.11
2.03
9.43
Surgery
7,704
Yes
70.26
2,621
9.76
91,764
0.84
23.08
Indonesia
2,020
Hepatitis
Viral
2.17
10.63
6.56
19-35
Female
722,928
72.7
4.62
0.63
Therapy
27,784
No
52.03
2,795
9.1
22,328
0.45
41.75
USA
2,012
Hepatitis
Genetic
15.17
1.9
4.76
61+
Male
561,804
56.94
4.06
1.12
Therapy
13,299
Yes
84.15
2,386
8.91
31,268
0.48
44.68
UK
2,001
Dengue
Genetic
15.71
6
2.38
61+
Other
5,779
70.58
2.59
6.71
Surgery
14,111
No
50.74
4,597
5.46
38,002
0.58
53.31
Turkey
2,015
Leprosy
Bacterial
8.2
8.51
5.24
19-35
Other
752,054
59.36
4.46
4.29
Therapy
2,255
No
54.29
40
6.66
19,720
0.88
44.02
Nigeria
2,001
Polio
Parasitic
11.57
0.25
7.95
36-60
Other
468,765
51.73
4.85
7.35
Therapy
5,371
No
54.4
4,203
7.97
84,658
0.77
46.28
Japan
2,009
Parkinson's Disease
Viral
14.36
8.32
6.88
19-35
Male
468,409
77.92
2
7.14
Surgery
30,145
Yes
73.31
213
8.24
48,993
0.71
21.84
India
2,013
Leprosy
Viral
9.75
4.81
0.33
36-60
Female
366,510
98.73
2.72
4.97
Surgery
33,714
No
73.8
1,034
5.63
76,056
0.72
88.94
Nigeria
2,011
Leprosy
Respiratory
14.47
3.13
5.56
36-60
Male
819,433
68.66
0.79
5.86
Medication
41,597
Yes
52.61
2,275
7.52
13,088
0.6
64.81
Mexico
2,007
Hepatitis
Metabolic
9.8
13.29
4.56
36-60
Male
893,309
97.51
4.75
7.07
Surgery
25,379
No
78.66
3,673
6.64
74,906
0.68
44.31
South Africa
2,023
Diabetes
Viral
1.61
15
7.66
36-60
Other
353,105
57.01
3.38
1.03
Medication
21,433
No
74.88
3,859
7.5
77,985
0.54
56.89
Argentina
2,005
Polio
Parasitic
14.08
1.03
1.78
19-35
Female
864,131
93.24
2.24
0.94
Therapy
41,524
No
92.16
332
2.96
92,640
0.56
34.37
Russia
2,017
Asthma
Infectious
3.1
10.77
7.61
0-18
Male
220,721
77.22
4.04
8.73
Therapy
34,101
No
74.86
4,772
8.39
77,293
0.43
70.94